Search results
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 2 hours agoAssertio Holdings (ASRT) has provided a detailed overview of their first-quarter financial...
Earnings call: Artivion reports robust growth in Q1 2024, raises guidance By Investing.com
Investing.com· 1 hour agoArtivion, Inc. (AORT) delivered a strong financial performance for the first quarter of 2024, with a...
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 4 hours agoQ: What doses of EDP-323 are you testing in the Phase IIa human challenge study? A: Jay Luly responded that they are testing two regimens: one with a consistent 600 mg dose
FibroGen Inc (FGEN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 4 hours agoThe study is still in the dose escalation phase, and it's too early to set a benchmark for success. The focus is on radiographic progression-free survival as a potential registration ...
Assertio Holdings Inc (ASRT) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
GuruFocus.com via Yahoo Finance· 4 hours agoTotal Sales: $31.9 million in Q1 2024, a slight decrease from $32.5 million in Q4 2023. Rolvedon Sales: $14.5 million in Q1 2024, up ...
AP source: J&J doses to be released, but many will be tossed
AOL· 7 days agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19...
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
GuruFocus.com via Yahoo Finance· 4 hours agoNet Revenue: $45.3 million for the quarter. Total Net Revenue: Exceeded $95 million over the first three quarters since launch. Earnings Per Share (EPS) ...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 1 hour ago...been observed in MTAP bladder cancerEnrollment is ongoing in the IDE397 and AMG 193 Phase 1 dose escalation and targeting development of joint Amgen / IDEAYA publication strategy in 2024First-patient-in (FPI... development candidate in H2 2024 to enable wholly-owned IDE397 combinationStrong...
$4 million bond issued for man accused of giving fatal dose of Benadryl to 3-year-old boy
WBNS-10TV Columbus· 4 days agoA Franklin County judge issued a $4 million bond for a man who allegedly gave a 3-year-old boy a...
Drs. Oz and Roizen: Non-drug ways to ease chronic pain
telegraphherald.com· 6 hours agoMore than 50 million U.S. adults contend with chronic pain — that is, pain that persists for more than three months. Almost 7 million find that it’s so ...